CDCA8 and central nervous system cancer: In this study, we demonstrated that high expression of CDCA8 was associated with advanced WHO grade III–IV and poor overall and disease-free survival, indicating CDCA8 may be a biomarker for the high-grade glioma patients’ disease progression and prognosis.